Bioidentical Hormone Therapy

Bioidentical hormone therapy, honestly explained.

The truth most BHRT clinics will not tell you: FDA-approved estradiol and micronized progesterone are already bioidentical. We prescribe what the evidence supports — not what the marketing sells — in Papillion and across Nebraska.

Self-pay · $225 initial · $125 follow-up · Telehealth in 16 states

Search "bioidentical hormone therapy" and you will find thousands of clinics promising that their "custom compounded" hormones are safer, more natural, and more effective than what your primary care doctor would prescribe. Most of that marketing is not supported by the evidence.

At Midwest Mind & Body Healthcare in Papillion, we offer bioidentical hormone therapy (BHRT) for perimenopausal and menopausal women — but we do it differently. We start with what the research, the FDA, and major professional societies actually say, and we are transparent about the fact that most patients do best on FDA-approved bioidentical hormones, not compounded ones. Compounded options have a real place in care, but a narrow one.

Our founder, Kim Wohlwend, MSN, APRN, is a dual ANCC board-certified Family Nurse Practitioner and Psychiatric-Mental Health Nurse Practitioner. Hormone therapy is part of a broader practice that also addresses mood, metabolism, sleep, and thyroid function — because hormones never exist in isolation.

The short version "Bioidentical" just means the hormone molecule is identical to what your body makes. Estradiol patches from a retail pharmacy are bioidentical. So is oral micronized progesterone (Prometrium). You do not need a compounding pharmacy to get bioidentical hormones — and for most women, you should not start there.

Start Here

What does "bioidentical" actually mean?

This is the single most misunderstood word in menopause care. Clarity matters, because the wrong definition leads patients to pay more, take less consistent doses, and sometimes end up on unsafe regimens.

A molecule, not a marketing term

Bioidentical means the hormone molecule is structurally identical to the one your own ovaries, adrenal glands, or testes produce. Estradiol is estradiol, whether it comes from a compounding pharmacy or a retail pharmacy. The atoms are arranged the same way.

Estradiol is bioidentical

Estrace (oral estradiol), Climara and Vivelle-Dot (transdermal patches), EstroGel and Divigel (transdermal gels), and Estring and Vagifem (vaginal estradiol) are all FDA-approved and all bioidentical. Same molecule your body made in your twenties.

Micronized progesterone is bioidentical

Prometrium is oral micronized progesterone — molecularly identical to the progesterone made by your ovaries. It is FDA-approved, widely available, and the preferred progestogen for most patients on estrogen therapy.

What is NOT bioidentical

Conjugated equine estrogens (Premarin, derived from pregnant mare urine) and synthetic progestins (medroxyprogesterone, norethindrone) are not bioidentical. These are the older "synthetic" hormones studied in the original Women's Health Initiative trial.

Where "natural" gets misleading

Compounding pharmacies often market their products as "natural" because the raw material is derived from plants (diosgenin from yam or soy). But FDA-approved bioidentical estradiol is made from the same plant-derived starting material. Both are processed in a lab. Neither is picked off a tree.

Why this matters

If a clinic tells you their compounded hormones are bioidentical but your pharmacy's Estrace is not, they are either misinformed or selling you something. The molecule is what makes hormone therapy safe and effective, not the pharmacy that mixed it.

Comparison

FDA-approved vs. compounded bioidentical.

Both can deliver the same molecule. The real differences are in manufacturing consistency, oversight, insurance coverage, and cost. Here is an honest side-by-side.

Recommended First

FDA-approved bioidentical

  • Tested for potency, purity, and consistency batch by batch.
  • Reliable dosing — what is on the label is what is in the tablet, patch, or gel.
  • Usually covered by commercial insurance and Medicare Part D when prescribed through a retail pharmacy.
  • Available in most doses needed for standard menopausal care.
  • Backed by the Endocrine Society, NAMS, and ACOG for first-line use.
  • Includes oral, transdermal patch, transdermal gel, vaginal tablet, vaginal ring, and vaginal cream options.
Specific Indications Only

Compounded bioidentical (cBHT)

  • Not FDA-tested for batch-to-batch consistency. Quality depends on the individual pharmacy.
  • Potency can vary meaningfully between fills and pharmacies — this has been documented in FDA testing.
  • Typically not covered by insurance. Paid out of pocket.
  • Useful when FDA-approved formulations cause allergy, when a dose outside commercial ranges is needed, or when a specific combination is not commercially available.
  • Not more natural and not automatically safer than FDA-approved versions.
  • See our compounded-medication disclosure for details.

When Compounded Is Appropriate

There are legitimate reasons to compound.

We are not anti-compounding. We are anti-reflex-compounding. Here are the specific clinical situations where a compounded bioidentical formulation is genuinely the right call.

Allergy to an FDA-approved formulation

Some patients react to a preservative, dye, or adhesive in commercial products — for example, the adhesive on a transdermal patch. A compounded cream or gel can avoid the offending ingredient.

Doses outside commercial ranges

Occasionally a patient needs a dose lower than the smallest FDA-approved option, or higher than the largest, for legitimate clinical reasons. Compounding makes that possible with individualized titration.

Testosterone therapy for women

There is currently no FDA-approved testosterone product for women in the United States. We prescribe a compounded testosterone cream at low physiologic doses when clinically indicated, for Nebraska patients only.

Combinations not commercially available

Rarely, a patient benefits from a combination not available as a single FDA-approved product. This is uncommon, and we prefer stacking two FDA-approved medications when possible.

What We Prescribe

Mostly FDA-approved. Compounded when it's the right tool.

Our standard approach is to start every patient on FDA-approved bioidentical hormones unless there is a clear reason to do otherwise. Most women never need a compounded prescription. When they do, we explain why and document the indication.

FDA-approved bioidentical estrogen — Estradiol (17β-estradiol):

  • Oral estradiol (Estrace, generic estradiol tablets). Convenient, well-studied, but slightly higher clot risk than transdermal.
  • Transdermal estradiol patches (Climara, Vivelle-Dot, Minivelle, Alora). Preferred route for most patients because transdermal estradiol does not raise clot risk the way oral does.
  • Transdermal estradiol gels and sprays (EstroGel, Divigel, Elestrin, Evamist). Flexible dosing, same transdermal safety advantage.
  • Vaginal estradiol (Estring ring, Vagifem / Yuvafem / Imvexxy tablets, Estrace cream). For vaginal dryness, painful sex, and urinary symptoms. Works locally with minimal systemic absorption. See our vaginal estrogen page.

FDA-approved bioidentical progesterone:

  • Oral micronized progesterone (Prometrium). The preferred progestogen for most women using systemic estrogen. Taken at bedtime for its mild sleep effect. Same molecule as ovarian progesterone.

Compounded options (when clinically indicated):

  • Compounded testosterone cream for women at low physiologic doses — Nebraska only, due to controlled-substance rules. See our testosterone therapy for women page.
  • Compounded estradiol or progesterone in specific cases: documented allergy to an FDA-approved formulation, need for a dose outside commercial ranges, or a combination not commercially available.

Related pages: perimenopause treatment · menopause HRT in Omaha · testosterone therapy for women.

What We Don't Do

The tests and products we don't use.

Predatory BHRT clinics make money on recurring tests and proprietary products that the evidence does not support. We skip these and spend the time on what actually helps.

No salivary hormone panels

Salivary hormone testing is not validated for clinical dosing decisions in menopausal hormone therapy. NAMS, the Endocrine Society, and ACOG all advise against using it to guide treatment. We dose based on symptoms and, when specifically indicated, serum labs.

No routine 24-hour urine panels

Panels like DUTCH are popular in the BHRT space but rarely change appropriate clinical decisions in standard menopausal care. We may order them in specific research-informed scenarios, but not as routine intake.

No hormone pellets

Pellets deliver testosterone at supraphysiologic doses, cannot be adjusted once inserted, and are not FDA-approved for women. Multiple professional societies advise against routine use. We use adjustable, removable, FDA-approved routes instead.

No supraphysiologic dosing

Goal hormone levels in therapy are levels appropriate for your life stage, not levels artificially pushed to what you had at 25. Over-replacement causes real harm: acne, hair loss, voice change, cardiovascular risk.

Our Approach

How BHRT works here.

01

Honest evaluation

A full intake covering symptoms, medical and family history, current medications, and goals. We order serum labs only when they will change a decision — FSH, estradiol, and thyroid studies when clinically indicated, not as a sales pitch.

02

Evidence-based plan

We start with FDA-approved bioidentical estradiol (usually transdermal) and FDA-approved micronized progesterone if you have a uterus. We add testosterone only when symptoms justify it and only for Nebraska patients. Compounded options only when there is a specific clinical indication.

03

Follow-up that actually follows up

Follow-up at 6 to 8 weeks, then as needed. We adjust based on how you feel and how you are tolerating the therapy, not based on a salivary panel result. Direct clinician access between visits through the patient portal.

Pricing

Transparent self-pay pricing.

Initial Visit

$225
Comprehensive hormone therapy intake.
  • Full symptom and medical history review
  • Evidence-based treatment plan
  • Prescriptions sent to your preferred pharmacy
  • Labs ordered only when clinically indicated

Follow-Up

$125
Per follow-up visit.
  • Typical cadence: 6 to 8 weeks, then as needed
  • Dose adjustments and refills
  • Direct clinician messaging through portal
  • Good-faith estimate provided on request

Hormone therapy is offered on a self-pay basis so that visit time is spent on clinical care, not insurance paperwork. FDA-approved bioidentical prescriptions sent to a retail pharmacy are typically covered by commercial insurance and Medicare Part D. Compounded prescriptions are usually out of pocket.

Where we see patients.

Hormone therapy is available in person at our Papillion, Nebraska office and by secure telehealth across 16 states for estradiol and progesterone. Testosterone therapy for women is available to Nebraska patients only (due to controlled-substance prescribing rules).

Nebraska Iowa Kansas Colorado Arizona Illinois Utah Idaho New Mexico Kentucky Montana North Dakota South Dakota Vermont New Hampshire Maine
Testosterone note: Compounded testosterone therapy for women is available to Nebraska patients only because of controlled-substance prescribing rules. Estradiol and progesterone are available across all 16 telehealth states.

FAQ

Honest answers about BHRT.

Is bioidentical the same as natural?

Not exactly. Bioidentical means molecularly identical to what your body makes. Both FDA-approved and compounded estradiol are bioidentical because they are the same molecule as your own estradiol. The raw material is usually derived from plants (yam or soy) in a lab, so calling it purely "natural" is a marketing overstatement on both sides of the FDA-approved vs. compounded line.

Is bioidentical safer than synthetic?

The bioidentical molecules — estradiol and micronized progesterone — do appear to have a better safety profile than some older synthetic hormones like conjugated equine estrogens and medroxyprogesterone, particularly for breast tissue and (with transdermal use) clot risk. The safety advantage comes from the molecule, not from whether it was compounded. FDA-approved bioidentical products give you the same safety benefit.

What's the difference between Estrace and compounded estradiol?

The estradiol molecule is identical. What differs is manufacturing and oversight. Estrace is FDA-approved and every tablet has been tested for potency, purity, and consistency. Compounded estradiol is mixed for an individual patient and is not subjected to the same batch-by-batch FDA quality testing. For most patients, the FDA-approved version is the better default and is usually covered by insurance.

Should I get salivary hormone testing?

No. Salivary hormone testing is not validated for clinical dosing decisions in menopausal hormone therapy. NAMS, the Endocrine Society, and ACOG advise against using it to guide treatment. We dose based on symptoms and, when needed, serum labs.

Are pellets safer?

No. Hormone pellets are not FDA-approved for women and typically deliver testosterone at supraphysiologic doses. They cannot be dose-adjusted once inserted and commonly cause androgenic side effects like acne, hair loss, and voice changes. We do not use them.

Why don't you prescribe BHRT pellets?

Because the evidence does not support them. Pellets produce unpredictable, often supraphysiologic hormone levels, cannot be removed if a patient has a side effect, and are not FDA-approved for women. We use safer, adjustable options: transdermal patches, gels, creams, vaginal inserts, and oral micronized progesterone.

Can I get bioidentical hormones by telehealth?

Yes. Estradiol and progesterone are available by secure telehealth in 16 states: Nebraska, Iowa, Kansas, Colorado, Arizona, Illinois, Utah, Idaho, New Mexico, Kentucky, Montana, North Dakota, South Dakota, Vermont, New Hampshire, and Maine. Testosterone therapy for women is Nebraska only due to controlled-substance prescribing rules.

What does the FDA say about compounded hormones?

The FDA has issued repeated consumer advisories about compounded bioidentical hormone therapy (cBHT), clarifying that compounded products are not FDA-approved, are not tested for safety or efficacy the same way FDA-approved drugs are, and that marketing claims suggesting cBHT is safer, more natural, or more effective than FDA-approved hormones are not supported by evidence. A 2020 National Academies report reached the same conclusion and recommended limiting compounded hormones to specific clinical situations — which is how we use them.

Bioidentical hormones, done right.

Honest, evidence-based BHRT without the salivary panels, pellets, or pressure. FDA-approved bioidentical estradiol and progesterone as the starting point, compounded options when clinically indicated. In Papillion and by telehealth across 16 states.

Book an Appointment